Cargando…

Data on the stability of darunavir/cobicistat suspension after tablet manipulation

The COVID-19 outbreak is now one of the most critical crises to manage for most of the national healthcare systems in the world. In the absence of authorised pharmacological treatments, many antiretrovirals, including darunavir/cobicistat fixed combination, are used off-label in the hospital wards a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zanon, D., Manca, A., De Nicolò, A., D'Avolio, A., Musazzi, U.M., Cilurzo, F., Maximova, N., Tomasello, C., Minghetti, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Pharmacology, Toxicology and Pharmaceutical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152873/ https://www.ncbi.nlm.nih.gov/pubmed/32292805 http://dx.doi.org/10.1016/j.dib.2020.105552

Ejemplares similares

Data on chloroquine/hydroxychloroquine content in compounded oral suspension after filtration and centrifugation
por: Musazzi, U.M., et al.
Publicado: (2020)

Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients
por: Zanon, D., et al.
Publicado: (2020)

Data on the determination of human epidermis integrity in skin permeation experiments by electrical resistance
por: Musazzi, Umberto M., et al.
Publicado: (2018)

Simulation data for an estimation of the maximum theoretical value and confidence interval for the correlation coefficient
por: Rocco, Paolo, et al.
Publicado: (2017)

Data on spray-drying processing to optimize the yield of materials sensitive to heat and moisture content
por: Magri, Giulia, et al.
Publicado: (2019)

Cobicistat/darunavir/cobicistat/darunavir/emtricitabine/tenofovir-alafenamide/darunavir/ritonavir: Various toxicities and off-label use: 9 case reports
Publicado: (2020)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Hordeum Vulgare Hull in the Design of Fast Disintegrating Tablets
por: Rajpurohit, H, et al.
Publicado: (2011)

Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection
por: Crutchley, Rustin D, et al.
Publicado: (2016)

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets
por: Remya, KS, et al.
Publicado: (2010)

Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations
por: Gutierrez‐Valencia, Alicia, et al.
Publicado: (2018)

FTIR and Raman Spectroscopic Investigations of a Norfloxacin/Carbopol934 Polymeric Suspension
por: Sahoo, S, et al.
Publicado: (2012)

Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet
por: Chabukswar, AR, et al.
Publicado: (2011)

Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19
por: Chen, Jun, et al.
Publicado: (2020)

Formulation and in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug
por: Gharti, KP, et al.
Publicado: (2012)

Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets
por: Pabari, RM, et al.
Publicado: (2012)

Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide
por: Chow, Wing, et al.
Publicado: (2020)

Formulation and Evaluation of Cephalexin Extended Release Matrix Tablets Using 3(2) Factorial Design
por: Jishnu, V, et al.
Publicado: (2011)

Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants
por: Moore, Katy, et al.
Publicado: (2022)

Influence of Organic Acids on Diltiazem HCl Release Kinetics from Hydroxypropyl Methyl Cellulose Matrix Tablets
por: Sateesha, SB, et al.
Publicado: (2010)

Design of Controlled Release Non-erodible Polymeric Matrix Tablet Using Microwave Oven-assisted Sintering Technique
por: Patel, DM, et al.
Publicado: (2011)

Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS
por: Putcharoen, Opass, et al.
Publicado: (2015)

Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”
por: Nicolini, Laura Ambra, et al.
Publicado: (2020)

Formulation and Evaluation of Cephalexin Extended-release Matrix Tablets Using Hydroxy Propyl Methyl Cellulose as Rate-controlling Polymer
por: Vijay, J, et al.
Publicado: (2012)

Effect of monotherapy with darunavir/cobicistat on viral load and semen quality of HIV-1 patients
por: López-Ruz, Miguel A., et al.
Publicado: (2018)

Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Standard manufacturing procedure for syrup and tablet forms of Jwarahara Dashemani
por: Kalsariya, Bharat D., et al.
Publicado: (2010)

Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
por: Navarro, Jordi, et al.
Publicado: (2016)

Ceftriaxone/cobicistat/darunavir/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022)

Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era
por: Squillace, Nicola, et al.
Publicado: (2018)

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
por: Solana-Altabella, Antonio, et al.
Publicado: (2022)

Dataset on the kinetics of the inhibition of PTP1B by the flavonoids and pheophytin A from Allophylus cominia
por: Semaan, D.G., et al.
Publicado: (2018)

The Disintegration Process in Microcrystalline Cellulose Based Tablets, Part 1: Influence of Temperature, Porosity and Superdisintegrants
por: Yassin, Samy, et al.
Publicado: (2015)

Gram scale preparation of clozapine N-oxide (CNO), a synthetic small molecule actuator for muscarinic acetylcholine DREADDs
por: van der Peet, Phillip L., et al.
Publicado: (2018)

The idiosyncratic drug-induced gene expression changes in HepG2 cells
por: Jiang, J., et al.
Publicado: (2017)

Data describing lack of effects of 17α-ethinyl estradiol on mammary gland morphology in female mice exposed during pregnancy and lactation
por: LaPlante, Charlotte D., et al.
Publicado: (2017)

A quantitative and non-invasive method for nanoparticle translocation and toxicity evaluation in a human airway barrier model
por: Zhang, Fan, et al.
Publicado: (2020)

PHARMIP: An insilico method to predict genetics that underpin adverse drug reactions
por: Zidan, Ahmad M., et al.
Publicado: (2019)

Computational Fluid Dynamics data for improving freeze-dryers design
por: Barresi, Antonello A., et al.
Publicado: (2018)

Dataset on the knowledge, attitudes and practices of university students towards antibiotics
por: Ayepola, Olayemi O., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8cbvckfbctm4opf2ufh288hg17